![]() | |
Names | |
---|---|
IUPAC name 2-(2-Methoxyphenyl)-2-(methylamino)cyclohexanone | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
PubChem CID | |
UNII |
|
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C14H19NO2 | |
Molar mass | 233.311 g·mol−1 |
Pharmacology | |
Legal status |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Methoxyketamine or 2-MeO-2-deschloroketamine is a designer drug of the arylcyclohexylamine class first reported in 1963. [1] It is an analog of ketamine in which the chlorine atom has been replaced with a methoxy group. Its synthesis by rearrangement of an amino ketone has been reported. [2] As an arylcyclohexylamine, methoxyketamine most likely functions as an NMDA receptor antagonist. It produces sedative, hallucinogenic, and (at high doses) anesthetic effects, but with a lower potency than ketamine itself.
|